Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 114 participants.

Also called NCT06726252

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 114 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06726252
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06726252. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-11-10 (actual); primary completion 2025-04-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR)
Acronym
OUFR
Condition
Fractional Flow Reserve
Intervention (Device)
FFR measurement and intravascular imaging
Lead sponsor
Harbin Medical University (class: other)
Collaborator
Peking University Third Hospital (class: other)
Collaborator
Panovision (class: not stated)
Collaborator
Capital Medical University (class: other)
Collaborator
The Second Affiliated Hospital of Harbin Medical University (class: other)
Collaborator
Affiliated Hospital of Jining Medical University (class: other)
Collaborator
Peking University First Hospital (class: other)

Record details

Record id
cardio:ct-nct06726252
Content hash
258b669342ddeda66de0a3b60a2a423cdf601432e7cd6442346c855584889f93